239 related articles for article (PubMed ID: 24408013)
1. Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.
Xu Y; He B; Pan Y; Deng Q; Sun H; Li R; Gao T; Song G; Wang S
Tumour Biol; 2014 May; 35(5):4153-69. PubMed ID: 24408013
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor gene FokI, TaqI, BsmI, and ApaI polymorphisms and susceptibility to pulmonary tuberculosis: a meta-analysis.
Lee YH; Song GG
Genet Mol Res; 2015 Aug; 14(3):9118-29. PubMed ID: 26345844
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and the susceptibility to breast cancer: a meta-analysis.
Lee YH; Song GG
Neoplasma; 2014; 61(5):607-16. PubMed ID: 25244980
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis.
Song GG; Lee YH
Immunol Invest; 2013; 42(7):661-72. PubMed ID: 24004063
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: a meta-analysis.
Lee YH; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2012 Jun; 39(6):6471-8. PubMed ID: 22290287
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: an updated meta-analysis.
Lee YH
Clin Exp Dermatol; 2019 Jul; 44(5):498-505. PubMed ID: 30474246
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor gene FokI but not TaqI, ApaI, BsmI polymorphism is associated with Hashimoto's thyroiditis: a meta-analysis.
Wang X; Cheng W; Ma Y; Zhu J
Sci Rep; 2017 Jan; 7():41540. PubMed ID: 28134349
[TBL] [Abstract][Full Text] [Related]
8. ApaI, BsmI, FokI and TaqI polymorphisms in the vitamin D receptor (VDR) gene and the risk of psoriasis: a meta-analysis.
Liu JL; Zhang SQ; Zeng HM
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):739-46. PubMed ID: 22540341
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor FokI, TaqI, and ApaI polymorphisms and susceptibility to systemic lupus erythematosus: an updated meta-analysis.
Bae SC; Lee YH
Clin Rheumatol; 2018 Jun; 37(6):1529-1537. PubMed ID: 29468338
[TBL] [Abstract][Full Text] [Related]
10. Association of the BsmI, ApaI, TaqI, Tru9I and FokI Polymorphisms of the Vitamin D Receptor Gene with Nephrolithiasis in the Turkish Population.
Cakir OO; Yilmaz A; Demir E; Incekara K; Kose MO; Ersoy N
Urol J; 2016 Mar; 13(1):2509-18. PubMed ID: 26945655
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.
Liu Y; Li C; Chen P; Li X; Li M; Guo H; Li J; Chu R; Wang H
PLoS One; 2013; 8(6):e66716. PubMed ID: 23826116
[TBL] [Abstract][Full Text] [Related]
12. Association between vitamin D receptor polymorphisms and vitiligo susceptibility: An updated meta-analysis.
Lee YH; Song GG
J Cosmet Dermatol; 2023 Mar; 22(3):969-979. PubMed ID: 36254395
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor TaqI, BsmI and ApaI polymorphisms and osteoarthritis susceptibility: a meta-analysis.
Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
Joint Bone Spine; 2009 Mar; 76(2):156-61. PubMed ID: 19073371
[TBL] [Abstract][Full Text] [Related]
14. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.
Lee YH; Bae SC; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2011 Aug; 38(6):3643-51. PubMed ID: 21110115
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between vitamin D receptor gene ApaI, BsmI, and TaqI polymorphisms and primary biliary cirrhosis risk: a meta-analysis.
Mo C; Lu Y; Deng Y; Wang J; Xie L; Li T; He Y; Qin X; Li S
Tumour Biol; 2014 May; 35(5):4913-20. PubMed ID: 24526415
[TBL] [Abstract][Full Text] [Related]
16. Associations between vitamin D receptor polymorphisms and breast cancer risk.
Wang J; He Q; Shao YG; Ji M; Bao W
Tumour Biol; 2013 Dec; 34(6):3823-30. PubMed ID: 23900677
[TBL] [Abstract][Full Text] [Related]
17. Association of vitamin D receptor BsmI, TaqI, FokI, and ApaI polymorphisms with susceptibility of chronic periodontitis: A systematic review and meta-analysis based on 38 case -control studies.
Mashhadiabbas F; Neamatzadeh H; Nasiri R; Foroughi E; Farahnak S; Piroozmand P; Mazaheri M; Zare-Shehneh M
Dent Res J (Isfahan); 2018; 15(3):155-165. PubMed ID: 29922333
[TBL] [Abstract][Full Text] [Related]
18. BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis.
Zintzaras E; Rodopoulou P; Koukoulis GN
Dis Markers; 2006; 22(5-6):317-26. PubMed ID: 17264402
[TBL] [Abstract][Full Text] [Related]
19. Association of FokI, TaqI, BsmI and ApaI polymorphisms with diabetic retinopathy: a pooled analysis of case-control studies.
Jiao J; Li Y; Xu S; Wu J; Yue S; Liu L
Afr Health Sci; 2018 Dec; 18(4):891-899. PubMed ID: 30766552
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus.
Mostowska A; Lianeri M; Wudarski M; Olesińska M; Jagodziński PP
Mol Biol Rep; 2013 Feb; 40(2):803-10. PubMed ID: 23065277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]